APPLICATION
ANDA203693
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-16
LATEST ACTION
2017-10-16
ROUTE
SUBLINGUAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
NITROGLYCERINDiscontinued
NITROGLYCERIN 0.4MG · TABLET · SUBLINGUAL
NITROGLYCERINDiscontinued
NITROGLYCERIN 0.6MG · TABLET · SUBLINGUAL
NITROGLYCERINDiscontinued
NITROGLYCERIN 0.3MG · TABLET · SUBLINGUAL
Approval history
2017-10-16UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.